Related Experiment Video
Updated: May 21, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
Silencing the killers: paracrine immune suppression in pancreatic cancer
Adrienne D Cox1, Kenneth P Olive
1Departments of Radiation Oncology and Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. adrienne_cox@med.unc.edu
Abstract:
Pancreatic cancers are characterized by high levels of inflammatory cells and profound immune suppression. In this issue of Cancer Cell, Bayne et al. and Pylayeva-Gupta et al. show that KRAS-driven, tumor cell-secreted GM-CSF recruits myeloid-derived suppressor cells to the stroma to abrogate tumor cell immune clearance by killer T lymphocytes.
Insights
Pancreatic cancers suppress the immune system. Tumor cells secrete GM-CSF, recruiting myeloid-derived suppressor cells to block killer T cells and hinder anti-tumor immunity.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Pancreatic cancers exhibit significant inflammatory cell infiltration and immune suppression.
- Understanding the mechanisms of immune evasion in pancreatic ductal adenocarcinoma (PDAC) is critical.
Discussion:
- Bayne et al. and Pylayeva-Gupta et al. identify Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as a key mediator in PDAC immune suppression.
- KRAS-driven tumor cells secrete GM-CSF, which attracts myeloid-derived suppressor cells (MDSCs) into the tumor stroma.
Key Insights:
- GM-CSF recruits MDSCs to the pancreatic tumor microenvironment.
- The influx of MDSCs abrogates the immune clearance of tumor cells by cytotoxic T lymphocytes (CTLs).
- This mechanism highlights a critical pathway for immune evasion in KRAS-mutant pancreatic cancer.
Outlook:
- Targeting GM-CSF or MDSC recruitment could represent a novel therapeutic strategy for pancreatic cancer.
- Further research into the interplay between tumor-secreted factors and immune cell infiltration is warranted.
- Developing immunotherapies that overcome MDSC-mediated suppression may improve patient outcomes.
More Related Videos
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...